Back to search

Article

CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltration

2023-08-02

Abstract excerpt

<h4>Background: </h4> Immunomodulatory (IM) subtype triple negative breast cancer (TNBC) has high immune cell signaling, cytokine signaling gene expression, and is more responsive to immunotherapy. The mechanism responsible for this phenomenon is not clear, but the gene, the cytotoxic and regulatory T cell molecule (CRTAM), seems to be involved in this process. Methods A total of 360 TNBC patients diagnosed with...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
5371f49c-7597-525d-be5b-7ffe1038dfa8
DOI
10.21203/rs.3.rs-3208041/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
CRTAM promotes antitumor immune response in triple negative breast cancer by enhancing CD8+ T cell infiltrationDOI 10.21203/rs.3.rs-3208041/v1
Select a neighboring publication to make it the new centre.